NASDAQ$PGEN
Precigen Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Precigen's financial performance increased due to collaboration and licensing revenues, offset by decreased product and service revenues. R&D expenses remained relatively stable, while SG&A expenses decreased. The company retired a significant amount of convertible notes, improving its financial position.
Precigen reported increased total revenues driven by collaboration and licensing agreements, offset by a decrease in product and service revenues. The company's loss from continuing operations improved compared to the prior year. Precigen also retired $144.0 million of convertible notes, strengthening its financial position.
- Total revenues increased by $13.4 million, or greater than 200%, compared to the third quarter of 2021.
- Collaboration and licensing revenues increased by $14.5 million due to revenue recognition from previously deferred agreements.
- The company retired $144.0 million of outstanding convertible notes due in July 2023, resulting in $5.4 million in savings.
- Cash, cash equivalents, short-term investments and restricted cash totaled $153.8 million as of September 30, 2022
Headline financials
Revenue & EPS history
Precigen · Revenue · Quarterly
$16.7M
Revenue by segment
Precigen · $18.4M total across 3 segments · Q4 2020
- Service revenue$14.3M+18.1%77.7%
- Product revenue$3.95M-25.4%21.5%
- Collab & licensing$148K-44.6%0.8%
Forward guidance
Precigen believes its cash runway is sufficient to advance its clinical priorities into Q4 2023.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q3 2022
+0.4%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+1.4%
Avg return
30 days after
50%
26 / 52 earnings
Positive
+31.0%
Q2 2023
Best reaction
-38.9%
Q4 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | — | — | — | |
| Q1 2026 | +1.7% | -0.2% | — | |
| Q3 2025 | +25.6% | +9.3% | -4.4% | |
| Q2 2025 | +6.1% | +63.9% | +110.6% | |
| Q1 2025 | -2.8% | -5.7% | +0.7% | |
| Q4 2024 | +0.6% | -4.5% | -22.3% | |
| Q3 2024 | -10.4% | -13.0% | -26.1% | |
| Q1 2024 | +6.7% | +2.2% | +25.9% | |
| Q4 2023 | +3.6% | +0.7% | -5.0% | |
| Q3 2023 | -13.5% | -19.8% | -6.3% | |
| Q2 2023 | +31.0% | +43.1% | +39.7% | |
| Q1 2023 | -9.5% | -4.0% | -6.3% | |
| Q4 2022 | +16.4% | -6.0% | -15.5% | |
| Q3 2022 | +11.2% | +18.1% | -2.5% | |
| Q2 2022 | +11.6% | +14.5% | +11.1% | |
| Q1 2022 | +3.2% | +8.0% | +23.2% | |
| Q4 2021 | -1.3% | -10.2% | -6.2% | |
| Q3 2021 | -7.1% | -11.8% | -33.3% | |
| Q2 2021 | +8.6% | +10.4% | +10.6% | |
| Q1 2021 | -0.2% | +5.7% | +9.5% | |
| Q4 2020 | +1.7% | +0.1% | -18.4% | |
| Q3 2020 | +22.2% | +20.4% | +69.7% | |
| Q2 2020 | -5.7% | -8.8% | -1.0% | |
| Q1 2020 | -5.9% | -4.2% | -4.7% | |
| Q4 2019 | -14.5% | -19.0% | -27.4% | |
| Q3 2019 | -1.1% | +2.0% | +6.3% | |
| Q2 2019 | -7.2% | -10.3% | -23.4% | |
| Q1 2019 | -1.1% | +0.7% | +22.2% | |
| Q4 2018 | -38.9% | -39.4% | -36.5% | |
| Q3 2018 | -19.3% | -24.4% | -32.1% | |
| Q2 2018 | -5.7% | -4.6% | -2.9% | |
| Q1 2018 | -19.5% | -13.0% | -9.3% | |
| Q4 2017 | +23.6% | +20.9% | +17.7% | |
| Q3 2017 | -25.3% | -19.7% | -15.9% | |
| Q2 2017 | -5.2% | -4.0% | -15.0% | |
| Q1 2017 | +21.5% | +32.0% | +15.0% | |
| Q4 2016 | +5.8% | +2.1% | -11.0% | |
| Q3 2016 | +14.1% | +24.0% | +15.7% | |
| Q2 2016 | +3.3% | +4.5% | +0.9% | |
| Q1 2016 | -5.1% | — | — | |
| Q4 2015 | -0.1% | — | — | |
| Q3 2015 | +9.7% | — | — | |
| Q2 2015 | -17.8% | — | — | |
| Q1 2015 | +3.2% | — | — | |
| Q4 2014 | +17.3% | — | — | |
| Q3 2014 | -3.9% | — | — | |
| Q2 2014 | -2.9% | — | — | |
| Q1 2013 | +2.9% | — | — | |
| Q1 2014 | -11.7% | — | — | |
| Q4 2013 | +5.5% | — | — | |
| Q3 2012 | +3.6% | — | — | |
| Q3 2013 | +3.6% | — | — | |
| Q2 2013 | -7.8% | — | — | |
| Q4 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q1 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro